Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.
NCT ID: NCT02195778
Last Updated: 2014-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2013-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Effectiveness of a Health Literacy Intervention in the Workplace
NCT01103986
Health Literacy in Patients With Congestive Heart Failure
NCT00508716
Evaluating a Low-Literacy Discharge Medication Education Tool
NCT00408733
Use of a Training Video to Teach Medical Students About Health Literacy
NCT01460953
Health Literacy in Geriatric Patients
NCT06971393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
About one third of the adult population in the United States has limited health literacy (Berkman ND, Davis TC, McCormack L. Health literacy:what is it? J Health Commun. 2010; 15 Suppl 2: 9-19). Initial assessment of regulatory compliance in research studies in the UAE indicated poor understanding of medical information by patients/subjects (AAMDHREC 12/55).
Health Literacy Survey (HLS) will be conducted on adults visiting the participating UAE hospitals/clinics. The survey will be conducted by a trained bilingual healthcare professional such as a team of medical residents.
The investigators study attempts to identify the population that are unable to understand health information or are impaired in their understanding of health information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young, 18 to 30
No interventions assigned to this group
Middle, 31 to 50
No interventions assigned to this group
Older, 51 to 70
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to consent
Exclusion Criteria
* Severly ill
* Unable to consent
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tawam Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Satish Chandra
Senior Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tawam Hospital
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD 262/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.